摘要
多焦点IOL的出现,是白内障摘除手术发展过程中的一个重要阶段,其能够为白内障摘除手术后患者提供相对良好的全程视力,显著提高术后脱镜率,从而提高患者的术后满意度.但是,发展到目前多焦点IOL植入术后仍不可避免地出现一些视觉不良症状,个别的甚至需要进行手术干预.因此,如何扬长避短,谨慎选择多焦点IOL植入的适应证,提高术后视觉质量是所有眼科医师均应关注的问题.IOL技术不会止步于多焦点IOL,会有不断发展,未来一定会出现医患选择上更加自由、适应证更加广泛且价格更为合理的多功能IOL,最终使IOL具有更多甚至全部人眼自然晶状体的生理状态和功能.
The occurrence of multifocal intraocular lens (MIOL) is known as an important period in the development of cataract surgery,which can provide a simultaneous vision without the use of spectacles or contact lenses.However,in the current stage,MIOL implantation may also lead to decreased visual acuity and increased risk of photic phenomena,thus in some instance a second procedure to exchange the MIOL is necessary.Optimizing visual outcomes of MIOL implantation and controlling adverse effects has become the focus for ophthalmologists.In the future,a more remarkable,flexible and high cost-effective intraocular lens (IOL),which can mimic human natural crystalline lens,should emerge.